High-resolution profiling of lung adenocarcinoma identifies expression subtypes with specific biomarkers and clinically relevant vulnerabilities — Sept. 19, 2022
Whijae Roh joined Pfizer. — July 19, 2021
Whijae Roh joined Gad Getz lab. — Oct. 22, 2017
Identification of copy number loss as a correlate of therapeutic resistance in melanoma patients treated with checkpoint blockade — Mar. 1, 2017
CPRIT Graduate Scholar Award — Dec. 15, 2014
Whijae Roh joined Andrew Futreal lab. — May 22, 2014